Compare Suncor Energy Inc. (SU) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Suncor Energy Inc. vs State Street SPDR S&P Biotech ETF — how do they compare? Suncor Energy Inc. trades at $63.76 (market cap $74.07B), while State Street SPDR S&P Biotech ETF trades at $159.08. The key difference: Suncor Energy Inc. pays a 2.7% dividend while State Street SPDR S&P Biotech ETF pays none, and State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, Suncor Energy Inc. nearer its low. Which is the better fit depends on your goals.
| SU | XBI | |
|---|---|---|
Market Cap | $74.07B | — |
Sector | Energy | Broad Market / Factor |
52-Week High | $69.73 | $164.28 |
52-Week Low | $38.17 | $86.92 |
Enterprise Value | $80.75B | — |
Dividend Yield | 2.7% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Suncor Energy (SU) trades at $62.73, up 4.38% today, with a bearish technical signal but strong fundamentals including a P/E of 11.79 and net margin of 14.7%. Recent Q2 2026 earnings beat estimates at $2.27 EPS, driven by higher crude realizations and refining margins (Reuters, 2026-08-04). The company maintains a consistent dividend of $0.60 per share and announced a CEO transition to Peter Zebedee in 2027.
Outlook is supported by solid cash flow and buybacks, but risks include commodity price volatility and operational disruptions. Analyst consensus is strongly bullish with 74% buy ratings, targeting upside from efficient operations and debt reduction, though technical weakness near support at $61 may limit near-term gains.
XBI trades at $159.15, up 0.71% with a bullish technical signal from moving averages. The biotech ETF shows strong momentum with a 17% monthly gain, driven by positive clinical data and M&A activity. Analyst coverage remains limited with a single hold rating, while institutional interest grows with recent $793,000 investment from Bay Colony Advisors.
Outlook remains positive given biotech sector resurgence, though elevated RSI suggests near-term overbought conditions. Key risks include sector volatility and regulatory uncertainty, but AI-driven drug discovery and strong pipeline developments provide growth catalysts for patient investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Suncor Energy Inc.
Suncor Energy Inc is an integrated energy company. The company's operations include oil sands development, production and upgrading, offshore oil and gas, petroleum refining in Canada and the U.S. and the company's PetroCanada retail and wholesale distribution networks. The company is developing petroleum resources while advancing the transition to a low-emissions future through investment in power, renewable fuels and hydrogen. It also conducts energy trading activities focused principally on the marketing and trading of crude oil, natural gas, byproducts, refined products and power.
Read more on SU →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
